Publications
Detailed Information
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Hyun-Seung | - |
dc.contributor.author | Kim, Jin Hyun | - |
dc.contributor.author | Phi, Ji Hoon | - |
dc.contributor.author | Kim, Young-Yim | - |
dc.contributor.author | Wang, Kyu-Chang | - |
dc.contributor.author | Kim, Seung-Ki | - |
dc.contributor.author | Cho, Byung-Kyu | - |
dc.contributor.author | Kim, Jeong Eun | - |
dc.date.accessioned | 2012-06-13T07:47:51Z | - |
dc.date.available | 2012-06-13T07:47:51Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY; Vol.81 6; 673-678 | ko_KR |
dc.identifier.issn | 0022-3050 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77042 | - |
dc.description.abstract | Objective To document the expression patterns of various matrixins, cytokines and angiogenic factors in plasma to assess their involvement in the pathogenesis of moyamoya disease (MMD). Methods This study included plasma samples from 20 MMD patients and nine healthy individuals. The plasma concentration of five matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-9, MMP-12), monocyte chemoattractant protein-1 (MCP-1), resistin, three interleukins (IL-1 beta, IL-6, IL-8), tumour necrosis factor-alpha, vascular endothelial growth factor (VEGF), platelet-derived growth factor BB (PDGF-BB) and basic fibroblast growth factor was determined using multianalyte profiling systems. The concentration of the tissue inhibitors of metalloproteinase (TIMP-1 and TIMP-2) was measured using ELISA. Gelatin zymography for MMP-2 and MMP-9 was also performed. Results MMD patients exhibited significantly higher plasma concentrations of MMP-9, MCP-1, IL-1 beta, VEGF and PDGF-BB, and lower plasma concentrations of MMP-3, TIMP-1 and TIMP-2 compared with healthy controls. Significant correlations were found among MMP-9, MCP-1, VEGF, PDGF-BB and TIMP-2 in MMD patients. Conclusion There were distinctive expression patterns of matrixins, cytokines and angiogenic factors in MMD patients, which seemed to correlate with disease pathogenesis. The balance between MMPs and TIMPs was disrupted in MMD and correlated with disease pathogenesis. Increased plasma levels of MCP-1 and VEGF in MMD patients may play a role in the recruitment of vascular progenitor cells and in the formation of collateral vessels. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | B M J PUBLISHING GROUP | ko_KR |
dc.title | Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 강현승 | - |
dc.contributor.AlternativeAuthor | 김진현 | - |
dc.contributor.AlternativeAuthor | 피지훈 | - |
dc.contributor.AlternativeAuthor | 김영임 | - |
dc.contributor.AlternativeAuthor | 김정은 | - |
dc.contributor.AlternativeAuthor | 왕규창 | - |
dc.contributor.AlternativeAuthor | 조병규 | - |
dc.contributor.AlternativeAuthor | 김승기 | - |
dc.identifier.doi | 10.1136/jnnp.2009.191817 | - |
dc.citation.journaltitle | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | - |
dc.description.citedreference | Kim JH, 2010, J NEUROSCI RES, V88, P510, DOI 10.1002/jnr.22228 | - |
dc.description.citedreference | Fujimura M, 2009, SURG NEUROL, V72, P476, DOI 10.1016/j.surneu.2008.10.009 | - |
dc.description.citedreference | Fujimura M, 2009, SURG NEUROL, V71, P442, DOI 10.1016/j.surneu.2008.02.031 | - |
dc.description.citedreference | Kallenbach K, 2009, J VASC SURG, V49, P750, DOI 10.1016/j.jvs.2008.11.001 | - |
dc.description.citedreference | Rafat N, 2009, STROKE, V40, P432, DOI 10.1161/STROKEAHA.108.529420 | - |
dc.description.citedreference | Kuroda S, 2008, LANCET NEUROL, V7, P1056 | - |
dc.description.citedreference | Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002 | - |
dc.description.citedreference | Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756 | - |
dc.description.citedreference | Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782 | - |
dc.description.citedreference | Papadopoulou C, 2008, CYTOKINE, V43, P181, DOI 10.1016/j.cyto.2008.05.009 | - |
dc.description.citedreference | Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491 | - |
dc.description.citedreference | Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664 | - |
dc.description.citedreference | Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387 | - |
dc.description.citedreference | Kim JE, 2008, CEREBROVASC DIS, V25, P580, DOI 10.1159/000132205 | - |
dc.description.citedreference | Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714 | - |
dc.description.citedreference | Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf | - |
dc.description.citedreference | Kang HS, 2006, NEUROSURGERY, V58, P1074, DOI 10.1227/01.NEU.0000215854.66011.4F | - |
dc.description.citedreference | Rundhaug JE, 2005, J CELL MOL MED, V9, P267 | - |
dc.description.citedreference | Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3 | - |
dc.description.citedreference | Hamano Y, 2003, CANCER CELL, V3, P589 | - |
dc.description.citedreference | Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100 | - |
dc.description.citedreference | Wu LH, 2003, GENES CELLS, V8, P225 | - |
dc.description.citedreference | de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003 | - |
dc.description.citedreference | Wang L, 2002, EXP HEMATOL, V30, P831 | - |
dc.description.citedreference | Pozzi A, 2002, ONCOGENE, V21, P272 | - |
dc.description.citedreference | Ferreras M, 2000, FEBS LETT, V486, P247 | - |
dc.description.citedreference | Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243 | - |
dc.description.citedreference | Wu LH, 2000, BIOCHEM BIOPH RES CO, V269, P808 | - |
dc.description.citedreference | Deguchi Y, 2000, PHARMACEUT RES, V17, P63 | - |
dc.description.citedreference | Yamamoto M, 1999, CIRC RES, V85, P912 | - |
dc.description.citedreference | Yamamoto M, 1998, STROKE, V29, P1188 | - |
dc.description.citedreference | HOSODA Y, 1997, CLIN NEUROL NEURO S2, V99, P203 | - |
dc.description.citedreference | TAKAHASHI A, 1993, NEUROSCI LETT, V160, P214 | - |
dc.description.citedreference | AOYAGI M, 1993, J CELL PHYSIOL, V154, P281 | - |
dc.description.citedreference | HOSHIMARU M, 1991, J NEUROSURG, V75, P267 | - |
dc.description.citedreference | AOYAGI M, 1991, J CELL PHYSIOL, V147, P191 | - |
dc.description.citedreference | KONO S, 1990, STROKE, V21, P1044 | - |
dc.description.citedreference | LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97 | - |
dc.description.citedreference | SCHWEIGERER L, 1987, NATURE, V325, P257 | - |
dc.description.citedreference | HOSODA Y, 1984, PATHOL ANNU, V19, P221 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.